Your browser doesn't support javascript.
loading
Modifiable Cardiometabolic Risk Factors in Survivors of Childhood Cancer: JACC: CardioOncology State-of-the-Art Review.
Hammoud, Rawan A; Mulrooney, Daniel A; Rhea, Isaac B; Yu, Christine; Johnson, Jason N; Chow, Eric J; Ehrhardt, Matthew J; Hudson, Melissa M; Ness, Kirsten K; Armstrong, Gregory T; Dixon, Stephanie B.
Afiliação
  • Hammoud RA; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Mulrooney DA; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Rhea IB; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Yu C; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Johnson JN; Department of Pediatric Medicine, Division of Endocrinology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Chow EJ; Division of Pediatric Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
  • Ehrhardt MJ; Fred Hutchinson Cancer Center, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
  • Hudson MM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Ness KK; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Dixon SB; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
JACC CardioOncol ; 6(1): 16-32, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38510292
ABSTRACT
The growing community of childhood cancer survivors faces a heavy burden of late onset morbidities and mortality, with cardiovascular diseases being the leading noncancer cause. In addition to demographics and cancer treatment exposures, which cannot be altered, cardiometabolic risk factors (obesity, hypertension, diabetes, and dyslipidemia) and frailty potentiate the risk of morbidity and mortality associated with chronic health conditions. Important opportunities exist to target these risk factors and improve late health outcomes for survivors. Unfortunately, limited evidence exists on the optimal methods to prevent, screen, and treat cardiometabolic risk factors among survivors, resulting in significant underdiagnosis and undertreatment. In this review, we discuss the prevalence of, risk factors for, current survivor-specific recommendations, and gaps in knowledge to mitigate potentially modifiable cardiometabolic risk factors and frailty among survivors of childhood cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article